Discover Oncology, published by SPRINGER, is an influential journal based in Germany that focuses on the latest advancements in the fields of oncology and endocrinology. With an evolving scope that spans critical research from 2021 to 2024, this journal aims to provide a platform for innovative ideas and research findings that can significantly impact clinical practices. Although it currently holds a Q3 ranking in several Cancer Research and Endocrine category quartiles, its commitment to open access ensures that relevant knowledge is available to a wider audience, facilitating the exchange of ideas among researchers, professionals, and students. As evidenced by its growing presence in various medical spheres, including a Q2 ranking in Endocrinology and Diabetes, the journal plays a crucial role in advancing multidisciplinary research that integrates oncology with broader biological and medical parameters. For those in the field, Discover Oncology serves as both a resource and a community hub, encouraging collaboration and exploration of emerging findings that can lead to novel therapeutic approaches.

Brain Stimulation, published by Elsevier Science Inc, stands at the forefront of the interdisciplinary fields of biophysics, neurology, and neuroscience. With an impressive Q1 ranking in its categories and notable Scopus rankings—evidencing its influence in the realm of clinical neurology and general neuroscience—it serves as a critical platform for researchers seeking to disseminate innovative findings related to the applications and mechanisms of brain stimulation techniques. As an esteemed journal with a history of publication since 2008, Brain Stimulation is dedicated to enhancing our understanding of brain function through rigorous scientific inquiry and provides insights that are invaluable for both practitioners and academics alike. This journal exemplifies the importance of advancing research in therapeutic brain interventions, making it a vital resource for anyone involved in the neurological sciences.

Clinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.

Intractable & Rare Diseases Research is a pioneering journal dedicated to advancing the understanding and treatment of rare and intractable diseases. Published by INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT in Japan, this esteemed journal serves as a critical platform for researchers, clinicians, and healthcare professionals to share groundbreaking findings and developments in the field. With its established Scopus ranking of #238 out of 636 in the General Medicine category, placing it in the 62nd percentile, and its classification in the Q3 quartile for 2023, it is recognized as a significant contributor to the literature on rare diseases. Operating without an open-access model, the journal ensures high-quality content cultivated through rigorous peer-review processes. Through its scope spanning from 2012 to 2024, the journal aspires to bridge gaps in knowledge and foster collaboration among interdisciplinary researchers, ultimately aiming to improve patient outcomes and enhance public health concerning these challenging conditions.

JOURNAL OF CLINICAL IMMUNOLOGY, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal in the field of immunology, with an impressive standing as reflected in its Q1 ranking in both Immunology and Immunology and Allergy for 2023. With a history of publication dating back to 1981 and an E-ISSN of 1573-2592, this journal aims to disseminate cutting-edge research on diagnostic methods, therapeutic strategies, and understanding the mechanisms underlying immune responses. Its significant impact is underscored by its Scopus rankings, where it is placed in the top 15% of journals covering immunology and microbiology. The journal does not currently operate under an Open Access model, yet offers a robust platform for sharing essential findings that contribute to advancements in clinical immunology. As a resource for researchers, professionals, and students, the JOURNAL OF CLINICAL IMMUNOLOGY is pivotal in fostering dialogue and disseminating knowledge that enhances our understanding of immune-related diseases.

STERREOTACTIC AND FUNCTIONAL NEUROSURGERY, published by KARGER, is a distinguished journal focusing on the evolving fields of neurosurgery and functional neurology. With its ISSN of 1011-6125 and E-ISSN of 1423-0372, this journal has been at the forefront of publishing innovative research since its inception in 1938, securing a prominent position within the scientific community through its commitment to high-quality peer-reviewed articles. As of 2023, it ranks in the Q3 quartile for Clinical Neurology and Q2 for Surgery, reflecting its impactful contributions and relevance to current medical practice. Researchers and practitioners alike will benefit from the journal’s exploration of novel techniques, therapeutic advancements, and clinical outcomes in stereotactic and functional neurosurgery, making it an invaluable resource for those aiming to stay abreast of the latest developments in this dynamic field. Although it does not currently offer open access, readers can access its content via institutional subscriptions, ensuring widespread dissemination of critical research findings aimed at improving patient care and advancing surgical methodologies.

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.

Epilepsi is an esteemed academic journal dedicated to advancing the field of epilepsy research and treatment, published by KARE PUBL. With its open access model established since 2017, the journal ensures that vital research findings are easily accessible to a global audience, thereby fostering collaboration and knowledge sharing among researchers, healthcare professionals, and students. The journal focuses on a comprehensive range of topics within neurology, including clinical studies, therapeutic advancements, and innovative approaches to epilepsy management. Located in Istanbul, Turkey, Epilepsi aims to bridge the gap between research and practice, enhancing understanding and patient care for individuals affected by epilepsy. Its commitment to high-quality, peer-reviewed content makes it a significant resource for anyone involved in epilepsy research or clinical practice.

Movement Disorders Clinical Practice, published by WILEY, is an essential peer-reviewed journal dedicated to advancing the understanding and treatment of movement disorders from a clinical perspective. With an ISSN of 2330-1619, this journal serves as a vital resource for researchers, clinicians, and students engaged in neurology and clinical neuroscience. Since its inception in 2014, the journal has established itself within the medical community, currently positioned in the Q2 category for both Neurology and Neurology (Clinical), reflecting its influence and reputation. Although it does not offer open access, the journal is integral for disseminating high-quality research and clinical insights, thereby contributing significantly to improved patient care and outcomes in the field of movement disorders. Based in Hoboken, NJ, it continues to attract contributions from leading experts and aims to foster a deeper understanding and dialogue surrounding contemporary challenges and advancements in movement disorder treatment.

The Journal of Movement Disorders, published by the Korean Movement Disorders Society, is a premier open access journal dedicated to advancing the field of neurology with a specific focus on movement disorders. Established in 2008 and indexed with ISSN 2005-940X and E-ISSN 2093-4939, this journal plays a vital role in disseminating high-quality research and clinical insights to a global audience. With an impressive Q2 ranking in both Neurology and Clinical Neurology categories for 2023, the journal continues to feature innovative research articles that contribute to better understanding and management of various movement disorders. Ranked 104th out of 400 in Clinical Neurology and 54th out of 192 in Neuroscience, the Journal of Movement Disorders offers an essential platform for researchers, healthcare professionals, and students alike, fostering collaboration and knowledge exchange in a rapidly evolving field.